Regal Assets Analytics

SanaCurrents Updates

Adverse events appear to hold back positive Scholar Rock data; SanaCurrents closing out coverage

By |2021-04-07T13:17:41-04:00April 6th, 2021|Categories: SanaCurrents, SanaCurrents Updates|Tags: |

Scholar Rock Holding Corp. (NASDAQ:SRRK) reported positive topline data from [...]

Marinus Pharma’s Epilepsy Drug Shows Promise; SanaCurrents Closing Out Coverage

By |2021-03-15T15:58:12-04:00March 15th, 2021|Categories: Bill Langbein, SanaCurrents, SanaCurrents Updates|Tags: |

Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) disclosed results of its phase II [...]

Immunovant Pauses Dosing in Trials; Elevated Cholesterol Not Measured Yet in WAIHA Trial

By |2021-02-04T09:34:33-05:00February 3rd, 2021|Categories: SanaCurrents, SanaCurrents Updates|Tags: |

Immunovant (NASDAQ:IMVT) said Tuesday it had paused dosing patients in [...]

Turning Point Trial Records Positive Results; Matinas’ Drug Does Not Prove Superiority

By |2021-02-01T11:49:26-05:00February 1st, 2021|Categories: SanaCurrents, SanaCurrents Updates|Tags: , |

Turning Point Therapeutics, Inc (NASDAQ:TPTX) said over the weekend that [...]

Go to Top